Mean platelet volume may be elevated in mitral valve prolapse and associated with the severity of prolapse

Atilla Icli1, Fatih Aksoy, Abdullah Dogan

  • 11Department of Cardiology, Ahi Evran University Training and Research Hospital, Kirsehir, Turkey.

Insights

Platelet activation, indicated by elevated mean platelet volume (MPV), may contribute to thromboembolic events in patients with mitral valve prolapse (MVP). Higher MPV in MVP patients correlates with increased mitral regurgitation and leaflet thickening.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarkers

Background:

  • Thromboembolic events are a known complication in patients with mitral valve prolapse (MVP).
  • The role of platelet activation in these events within the MVP population remains unclear.
  • Mean platelet volume (MPV) is a potential indicator of platelet activation.

Purpose of the Study:

  • To investigate mean platelet volume (MPV) levels in patients with mitral valve prolapse (MVP).
  • To determine the association between MPV and the severity of MVP, including mitral regurgitation and leaflet morphology.

Main Methods:

  • A comparative study involving 312 patients diagnosed with MVP and 240 healthy control participants.
  • Linear regression analysis was employed to assess the relationship between MPV and echocardiographic parameters of MVP severity.

Main Results:

  • Patients with MVP exhibited significantly higher mean platelet volume (MPV) compared to control participants (8.9 ± 0.7 fL vs. 7.9 ± 0.6 fL, P = .001).
  • MPV was found to be independently associated with the degree of mitral regurgitation (β = .23, P = .001), maximal leaflet displacement (β = .24, P = .001), and the thickness of both anterior (β = .47, P = .001) and posterior leaflets (β = .22, P = .02).

Conclusions:

  • Mean platelet volume (MPV) is elevated in patients with mitral valve prolapse (MVP).
  • Elevated MPV is independently associated with key indicators of MVP severity, suggesting a potential role in disease progression or complications.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...